Comparison of urinary adiponectin in the presence of metabolic syndrome in peri- and postmenopausal women

Abstract Objectives To find the association between urinary adiponectin and metabolic syndrome (MetS) in peri- and postmenopausal women and its potential application as a noninvasive screening for MetS. Methods A cross-sectional study was conducted in healthy peri- and postmenopausal women (defined...

Full description

Bibliographic Details
Main Authors: Patsama Vichinsartvichai, Rattana Teeramara, Titima Jirasawas, Prirayapak Sakoonwatanyoo
Format: Article
Language:English
Published: BMC 2022-03-01
Series:BMC Women's Health
Subjects:
Online Access:https://doi.org/10.1186/s12905-022-01655-8
_version_ 1818315634892603392
author Patsama Vichinsartvichai
Rattana Teeramara
Titima Jirasawas
Prirayapak Sakoonwatanyoo
author_facet Patsama Vichinsartvichai
Rattana Teeramara
Titima Jirasawas
Prirayapak Sakoonwatanyoo
author_sort Patsama Vichinsartvichai
collection DOAJ
description Abstract Objectives To find the association between urinary adiponectin and metabolic syndrome (MetS) in peri- and postmenopausal women and its potential application as a noninvasive screening for MetS. Methods A cross-sectional study was conducted in healthy peri- and postmenopausal women (defined by STRAW + 10 staging) aged at least 40 years who attended annual check-ups or menopause clinics were recruited. Baseline demographic data, MENQOL, anthropometric measurements, blood pressure, laboratory (FBS, total cholesterol, HDL-C, LDL-C, TG), and urinary adiponectin were collected. The MetS was diagnosed according to JIS 2009. Results 290 peri- and postmenopausal women had participated. The prevalence of Mets among our participants was 18%. Urinary adiponectin levels were similar in peri- and postmenopausal women with and without MetS (2.6 ± 2.2 vs. 2.3 ± 1.9 ng/mL, respectively, P = 0.55). Urinary adiponectin provides no diagnostic value for MetS (AUC = 0.516). Conclusions Urinary adiponectin has no role in screening and diagnosing MetS in peri- and postmenopausal women. The quest toward noninvasive screening for MetS is still going on.
first_indexed 2024-12-13T09:08:40Z
format Article
id doaj.art-ee8a8ebe5bf844468180ce53bde4f0ae
institution Directory Open Access Journal
issn 1472-6874
language English
last_indexed 2024-12-13T09:08:40Z
publishDate 2022-03-01
publisher BMC
record_format Article
series BMC Women's Health
spelling doaj.art-ee8a8ebe5bf844468180ce53bde4f0ae2022-12-21T23:53:01ZengBMCBMC Women's Health1472-68742022-03-012211710.1186/s12905-022-01655-8Comparison of urinary adiponectin in the presence of metabolic syndrome in peri- and postmenopausal womenPatsama Vichinsartvichai0Rattana Teeramara1Titima Jirasawas2Prirayapak Sakoonwatanyoo3Department of Obstetrics and Gynecology, Faculty of Medicine Vajira Hospital, Navamindradhiraj UniversityDepartment of Obstetrics and Gynecology, Faculty of Medicine Vajira Hospital, Navamindradhiraj UniversityDepartment of Obstetrics and Gynecology, Faculty of Medicine Vajira Hospital, Navamindradhiraj UniversityDepartment of Clinical Pathology, Faculty of Medicine Vajira Hospital, Navamindradhiraj UniversityAbstract Objectives To find the association between urinary adiponectin and metabolic syndrome (MetS) in peri- and postmenopausal women and its potential application as a noninvasive screening for MetS. Methods A cross-sectional study was conducted in healthy peri- and postmenopausal women (defined by STRAW + 10 staging) aged at least 40 years who attended annual check-ups or menopause clinics were recruited. Baseline demographic data, MENQOL, anthropometric measurements, blood pressure, laboratory (FBS, total cholesterol, HDL-C, LDL-C, TG), and urinary adiponectin were collected. The MetS was diagnosed according to JIS 2009. Results 290 peri- and postmenopausal women had participated. The prevalence of Mets among our participants was 18%. Urinary adiponectin levels were similar in peri- and postmenopausal women with and without MetS (2.6 ± 2.2 vs. 2.3 ± 1.9 ng/mL, respectively, P = 0.55). Urinary adiponectin provides no diagnostic value for MetS (AUC = 0.516). Conclusions Urinary adiponectin has no role in screening and diagnosing MetS in peri- and postmenopausal women. The quest toward noninvasive screening for MetS is still going on.https://doi.org/10.1186/s12905-022-01655-8Urinary adiponectinMetabolic syndromeMenopauseMenopausal transition
spellingShingle Patsama Vichinsartvichai
Rattana Teeramara
Titima Jirasawas
Prirayapak Sakoonwatanyoo
Comparison of urinary adiponectin in the presence of metabolic syndrome in peri- and postmenopausal women
BMC Women's Health
Urinary adiponectin
Metabolic syndrome
Menopause
Menopausal transition
title Comparison of urinary adiponectin in the presence of metabolic syndrome in peri- and postmenopausal women
title_full Comparison of urinary adiponectin in the presence of metabolic syndrome in peri- and postmenopausal women
title_fullStr Comparison of urinary adiponectin in the presence of metabolic syndrome in peri- and postmenopausal women
title_full_unstemmed Comparison of urinary adiponectin in the presence of metabolic syndrome in peri- and postmenopausal women
title_short Comparison of urinary adiponectin in the presence of metabolic syndrome in peri- and postmenopausal women
title_sort comparison of urinary adiponectin in the presence of metabolic syndrome in peri and postmenopausal women
topic Urinary adiponectin
Metabolic syndrome
Menopause
Menopausal transition
url https://doi.org/10.1186/s12905-022-01655-8
work_keys_str_mv AT patsamavichinsartvichai comparisonofurinaryadiponectininthepresenceofmetabolicsyndromeinperiandpostmenopausalwomen
AT rattanateeramara comparisonofurinaryadiponectininthepresenceofmetabolicsyndromeinperiandpostmenopausalwomen
AT titimajirasawas comparisonofurinaryadiponectininthepresenceofmetabolicsyndromeinperiandpostmenopausalwomen
AT prirayapaksakoonwatanyoo comparisonofurinaryadiponectininthepresenceofmetabolicsyndromeinperiandpostmenopausalwomen